Endovascular Therapy for Acute PE: SCAI/SIR Update on Ongoing and Completed RCTs-Panel Discussion on Clinical Trials

Video Transcription

Video Summary

The panel discussion emphasized the importance of evidence-based randomized trials in improving patient care and developing guidelines in post-market interventions, particularly in pulmonary embolism (PE) treatments. Despite advances, only a small percentage of hospitals perform major PE interventions, highlighting the need for standardized approaches. It's critical to enroll patients in trials to ensure comprehensive data and avoid biases. Experts discussed catheter-directed therapy (CDT), thrombectomy, and considerations for anesthesia use. While current practices vary, these trials aim to refine patient treatment algorithms. The event concluded with appreciation for the collaboration between organizations like Sky, SIR, and NIH.

Keywords

pulmonary embolism

randomized trials

catheter-directed therapy

post-market interventions

patient care guidelines